In Spain, there is a Clinical Reference Centre officially recognized by the Ministry of Health on lipodystrophies. The University Clinical Hospital of Santiago de Compostela, and in particular, its Endocrinology and Nutrition Service
Currently, it is the only center with experience in the diagnosis and treatment of rare forms of lipodystrophy. This Lipodystrophy Unit is directed by Prof. David Araújo-Vilar, and has the professionals and equipment necessary for clinical evaluation, molecular diagnosis and specific treatment for this type of disorders. In addition, this service is the only one in Spain authorized to administer treatment with Recombinant Human Leptin for compassionate use on patients with Generalized Lipodystrophy.
Simultaneously with the medical activity, Dr. Araújo directs the Thyroid and Metabolic Diseases Unit (UETeM or its acronym in Spanish) of the Department of Medicine of the University of Santiago de Compostela, which currently focuses its research lines in the field of lipodystrophies, particularly, in the study of the molecular basis of the Berardinelli-Seip Syndrome (especially in the forms associated with neurodegeneration) and Familial Partial Lipodystrophy, and researching for new therapeutic strategies
Parallel to this unit, the Hospital of La Paz in Madrid, develops another line of research that has as main figures Margarita Lopez Trascasa (Main Investigator) and Fernando Corvillo Rodríguez (Predoctoral Researcher) who are developing various studies related to Lipodystrophies.